Atlas Trials

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Clinical trial NCT05521984 · RECRUITING

Trial details

NCT number
NCT05521984
Sponsor
Washington University School of Medicine
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Pediatric Brain TumorPediatric Solid Tumor
Start date
2023-04-03
Primary completion
2031-03-31
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.